Scott R Plotkin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Idiopathic Pulmonary Fibrosis

Metastatic Colorectal Cancer

Top Venues

Science advances

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Scott R Plotkin, Kaleb H Yohay, Phioanh L Nghiemphu, Christine T Dinh, Dusica Babovic-Vuksanovic, Vanessa L Merker, Annette Bakker, Geoffrey Fell, Lorenzo Trippa, Jaishri O Blakely, null null
Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors. The New England journal of medicine 390 (24) (2024)
Simeng Lu, Zhenzhen Yin, Jie Chen, Limeng Wu, Yao Sun, Xing Gao, Peigen Huang, Justin T Jordan, Scott R Plotkin, Lei Xu
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis. Cancers 16 (11) (2024)
Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science advances 10 (18) (2024)
Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science advances 10 (18) (2024)
Scott R Plotkin, Kaleb H Yohay, Phioanh L Nghiemphu, Christine T Dinh, Dusica Babovic-Vuksanovic, Vanessa L Merker, Annette Bakker, Geoffrey Fell, Lorenzo Trippa, Jaishri O Blakely, null null
Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors. The New England journal of medicine 390 (24) (2024)
Simeng Lu, Zhenzhen Yin, Jie Chen, Limeng Wu, Yao Sun, Xing Gao, Peigen Huang, Justin T Jordan, Scott R Plotkin, Lei Xu
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis. Cancers 16 (11) (2024)
Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science advances 10 (18) (2024)
Scott R Plotkin, Kaleb H Yohay, Phioanh L Nghiemphu, Christine T Dinh, Dusica Babovic-Vuksanovic, Vanessa L Merker, Annette Bakker, Geoffrey Fell, Lorenzo Trippa, Jaishri O Blakely, null null
Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors. The New England journal of medicine (2024)
Philipp Karschnia, Sylvia C Kurz, Priscilla Kaliopi Brastianos, Sebastian F Winter, Amanda Gordon, SooAe Jones, Michelle Pisapia, Naema Nayyar, Joerg-Christian Tonn, Tracy T Batchelor, Scott R Plotkin, Jorg Dietrich
Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Primary CNS Lymphoma Patients Treated With Methotrexate-Based Regimens. Neurology (2023)
Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Michael J Fisher, Rakesh K Jain, James Tonsgard, Nicole J Ullrich, Coretta Thomas, Lloyd J Edwards, Bruce R Korf, Roger J Packer, Matthias A Karajannis, Jaishri O Blakely
Multicenter, prospective, phase 2 study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro-oncology (2023)
Kavita Y Sarin, John Kincaid, Brittney R Sell, Jahanbanoo Shahryari, Matthew A J Duncton, Elaine Morefield, Wenchao Sun, Karol Prieto, Omar Chavez-Chiang, Carlos Moran Segura, Jonathan V Nguyen, Roderick T Bronson, Scott R Plotkin, Gerd G Kochendoerfer, Peter Fenn, Michael A Wootton, Christopher Powala, Mark P de Souza, Kenneth Y Tsai
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma. Science translational medicine 15 (717) (2023)
Philipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, Deborah A Forst, Elizabeth Gerstner, Justin T Jordan, Ina Ly, Scott R Plotkin, Nancy Wang, Maria Martinez-Lage, Sebastian F Winter, Joerg-Christian Tonn, Kai Rejeski, Louisa von Baumgarten, Daniel P Cahill, Brian V Nahed, Ganesh M Shankar, Jeremy S Abramson, Jeffrey A Barnes, Areej R El-Jawahri, Ephraim P Hochberg, P Connor Connor Johnson, Jacob D Soumerai, Ronald W Takvorian, Yi-Bin Chen, Matthew J Frigault, Jorg Dietrich
Neurotoxicity and management of primary and secondary CNS lymphoma after adoptive immunotherapy with CD19-directed CAR T-cells. Neuro-oncology (2023)
Justin T Jordan, Christina C Orr, Raquel D Thalheimer, Josephine V Cambillo, Roberta L Beauchamp, Ghalib Shaikh, Alona Muzikansky, Anat Stemmer-Rachamimov, Marco Giovannini, Michel Kalamarides, Fred G Barker, Vijaya Ramesh, Scott R Plotkin
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neuro-oncology advances 5 (1) (2023)
K Ina Ly, Vanessa L Merker, Wenli Cai, Miriam A Bredella, Alona Muzikansky, Raquel D Thalheimer, Jennifer Liwei Da, Christina C Orr, Hamilton P Herr, Mary E Morris, Connie Y Chang, Gordon J Harris, Scott R Plotkin, Justin T Jordan
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI. Neurology (2022)
Matthew J Frigault, Jorg Dietrich, Kathleen Gallagher, Mark J Roschewski, Justin T Jordan, Deborah A Forst, Scott R Plotkin, Daniella Cook, Keagan S Casey, Kevin A Lindell, Gabriel D Depinho, Katelin Katsis, Eva Lynn Elder, Mark B Leick, Bryan Choi, Nora Horick, Frederic Preffer, Meredith Saylor, Steven McAfee, Paul V O'Donnell, Thomas R Spitzer, Bimalangshu Dey, Zachariah DeFilipp, Areej El-Jawahri, Tracy T Batchelor, Marcela V Maus, Yi-Bin Chen
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial. Blood 139 (15) (2022)
Rebecca Burns, Kristin Niendorf, Kathleen Steinberg, Amy Mueller, Ina Ly, Justin T Jordan, Scott R Plotkin, Stephanie R Hicks
Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis. American journal of medical genetics. Part A 188 (8) (2022)
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, Brigitte C Widemann, James H Tonsgard, Jaishri O Blakely, Jeffrey C Allen, Elizabeth K Schorry, Bruce R Korf, Nathan J Robison, Stewart Goldman, Alexander A Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta T Robinson, Gary R Cutter, Lloyd J Edwards, Eva Dombi, Nancy Ratner, Roger Packer, Michael J Fisher
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
Sheilagh M Maguiness, Yemima D Berman, Nathan Rubin, Melissa Dodds, Scott R Plotkin, Claire Wong, Christopher L Moertel, null null
Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1. Neurology 97 (7 Suppl 1) (2021)
Shivani Ahlawat, K Ina Ly, Laura M Fayad, Michael J Fisher, Andrés J Lessing, Dale J Berg, Johannes M Salamon, Victor-Felix Mautner, Dusica Babovic-Vuksanovic, Eva Dombi, Gordon Harris, Scott R Plotkin, Jaishri Blakeley, null null
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment. Neurology 97 (7 Suppl 1) (2021)
Matthias A Karajannis, Audrey Mauguen, Ekrem Maloku, Qingwen Xu, Erin M Dunbar, Scott R Plotkin, Anna Yaffee, Shiyang Wang, J Thomas Roland, Chandranath Sen, Dimitris G Placantonakis, John G Golfinos, Jeffrey C Allen, Nicholas A Vitanza, Luis A Chiriboga, Robert J Schneider, Jingjing Deng, Thomas A Neubert, Judith D Goldberg, David Zagzag, Filippo G Giancotti, Jaishri O Blakely
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. Molecular cancer therapeutics 20 (9) (2021)
Limeng Wu, Sasa Vasilijic, Yao Sun, Jie Chen, Lukas David Landegger, Yanling Zhang, Wenjianlong Zhou, Jun Ren, Samuel Early, Zhenzhen Yin, William W Ho, Na Zhang, Xing Gao, Grace Y Lee, Meenal Datta, Jessica E Sagers, Alyssa Brown, Alona Muzikansky, Anat O Stemmer-Rachamimov, Luo Zhang, Scott R Plotkin, Rakesh K Jain, Konstantina M Stankovic, Lei Xu
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models. Science translational medicine 13 (602) (2021)
Ashley Cannon, Dominique C Pichard, Pamela L Wolters, Sarah Adsit, Gregg Erickson, Andrés J Lessing, Tanja Dudenbostel, Whitney Narmore, Claas Röhl, Tena Rosser, Brigitte C Widemann, Jaishri O Blakeley, Scott R Plotkin, null null
Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials. Neurology 97 (7 Suppl 1) (2021)
Raquel D Thalheimer, Vanessa L Merker, K Ina Ly, Amanda Champlain, Jennifer Sawaya, Naomi L Askenazi, Hamilton P Herr, Jennifer L W Da, Justin T Jordan, Alona Muzikansky, Elizabeth Morehouse Pearce, Fernanda H Sakamoto, Jaishri O Blakeley, R Rox Anderson, Scott R Plotkin, null null
Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials. Neurology 97 (7 Suppl 1) (2021)
Andrea M Gross, Scott R Plotkin, Brigitte C Widemann, null null
[REiNS] NF Clinical Trials - REiNS Collaboration 2020 Recommendations: Looking Back and Moving Ahead. Neurology (2021)
Srivandana Akshintala, Nashwa Khalil, Kaleb Yohay, Alona Muzikansky, Jeffrey C Allen, Anna Yaffe, Andrea M Gross, Michael J Fisher, Jaishri O Blakeley, Beverly Oberlander, Miriam Pudel, Celia Engelson, Jaime Obletz, Carole Mitchell, Brigitte C Widemann, David A Stevenson, Scott R Plotkin, null null
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2. Neurology 97 (7 Suppl 1) (2021)
Andrew B Lassman, Patrick Y Wen, Martin J Van Den Bent, Scott R Plotkin, Annemiek M E Walenkamp, Adam L Green, Kai Li, Christopher J Walker, Hua Chang, Sharon Tamir, Leah Henegar, Yao Shen, Mariano J Alvarez, Andrea Califano, Yosef Landesman, Michael G Kauffman, Sharon Sacham, Morten Mau Sorensen
A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Vanessa L Merker, Andrés J Lessing, Irene Moss, Maureen Hussey, Beverly Oberlander, Traceann Rose, Raquel Thalheimer, Tracy Wirtanen, Pamela L Wolters, Andrea M Gross, Scott R Plotkin, null null
Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS. Neurology 97 (7 Suppl 1) (2021)
Ana Maria Vranceanu, Emily L Zale, Christopher J Funes, Eric A Macklin, Jessica L McCurley, Elyse R Park, Justin T Jordan, Ann Lin, Scott R Plotkin
Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial. JMIR research protocols 7 (10) (2018)